Renal Nerve Stimulation: Complete Versus Incomplete Renal Sympathetic Denervation
Overview
Authors
Affiliations
Purpose: Blood pressure (BP) reduction after renal sympathetic denervation (RDN) is highly variable. Renal nerve stimulation (RNS) can localize sympathetic nerves. The RNS trial aimed to investigate the medium-term BP-lowering effects of the use of RNS during RDN, and explore if RNS can check the completeness of the denervation.
Material And Methods: Forty-four treatment-resistant hypertensive patients were included in the prospective, single-center RNS trial. The primary study endpoint was change in 24-h BP at 6- to 12-month follow-up after RDN. The secondary study endpoints were the acute procedural RNS-induced BP response before and after RDN; number of antihypertensive drugs at follow-up; and the correlation between the RNS-induced BP increase before versus after RDN (delta [Δ] RNS-induced BP).
Results: Before RDN, the RNS-induced systolic BP rise was 43(±21) mmHg, and decreased to 9(±12) mmHg after RDN ( < 0.001). Mean 24-h systolic/diastolic BP decreased from 147(±12)/82(±11) mmHg at baseline to 135(±11)/76(±10) mmHg ( < 0.001/<0.001) at follow-up (10 [6-12] months), with 1 antihypertensive drug less compared to baseline. The Δ RNS-induced BP and the 24-h BP decrease at follow-up were correlated for systolic ( = 0.44, = 0.004) and diastolic ( = 0.48, = 0.003) BP. Patients with ≤0 mmHg residual RNS-induced BP response after RDN had a significant lower mean 24-h systolic BP at follow-up compared to the patients with >0 mmHg residual RNS-induced BP response (126 ± 4 mmHg versus 135 ± 10 mmHg, = 0.04). 83% of the patients with ≤0 mmHg residual RNS-induced BP response had normal 24-h BP at follow-up, compared to 33% in the patients with >0 mmHg residual RNS-induced BP response ( = 0.023).
Conclusion: The use of RNS during RDN leads to clinically significant and sustained lowering of 24-h BP with fewer antihypertensive drugs at follow-up. RNS-induced BP changes were correlated with 24-h BP changes at follow-up. Moreover, patients with complete denervation had significant lower BP compared to the patients with incomplete denervation.
Autonomic control of ventricular function in health and disease: current state of the art.
van Weperen V, Ripplinger C, Vaseghi M Clin Auton Res. 2023; 33(4):491-517.
PMID: 37166736 PMC: 10173946. DOI: 10.1007/s10286-023-00948-8.
Katsurada K, Kario K Hypertens Res. 2023; 46(6):1462-1470.
PMID: 36991064 DOI: 10.1038/s41440-023-01266-2.
Huang H, Cheng H, Chia Y, Li Y, Van Minh H, Siddique S J Clin Hypertens (Greenwich). 2022; 24(9):1187-1193.
PMID: 36196464 PMC: 9532907. DOI: 10.1111/jch.14554.
Device-Based Sympathetic Nerve Regulation for Cardiovascular Diseases.
Li L, Hu Z, Xiong Y, Yao Y Front Cardiovasc Med. 2021; 8:803984.
PMID: 34957267 PMC: 8695731. DOI: 10.3389/fcvm.2021.803984.